| Mr William B Schmelzer, MSW, ACSW, LCSW | |
|
903 2nd St, Wausau, WI 54403-4705 | |
| (715) 842-3346 | |
| (715) 842-3344 |
| Full Name | Mr William B Schmelzer |
|---|---|
| Gender | Male |
| Speciality | Social Worker - Clinical |
| Location | 903 2nd St, Wausau, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013065614 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 272123 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr William B Schmelzer, MSW, ACSW, LCSW T4546 Little Trappe Rd, Wausau, WI 54403-9420 Ph: (715) 539-3851 | Mr William B Schmelzer, MSW, ACSW, LCSW 903 2nd St, Wausau, WI 54403-4705 Ph: (715) 842-3346 |
News Archive
According to a study published Thursday, a brief screening in a pediatrician's office can detect autism-like symptoms in children as young as 12 months old, giving them an important head start on treatment. The screening test used in the study also flagged some babies who later turned out to be developing normally, raising a false alarm for families. But early diagnosis and treatment of autism and other developmental delays are thought to improve outcomes, and researchers said the benefits of early intervention outweighed the downsides.
A Texas AgriLife Research scientist and fellow researchers have discovered that arginine, an amino acid, reduces fat mass in diet-induced obese rats and could help fight human obesity.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced the launch of piperacillin and tazobactam for injection in the United States. The medication is a generic version of Zosyn, the world's leading injectable antibiotic, from Pfizer. Piperacillin and tazobactam injection posted 2009 U.S. sales of more than $855 million.
4SC, a drug discovery and development company focused on autoimmune and cancer indications, today announced that initial safety and efficacy data from its ongoing Phase II Study with resminostat, a pan-Histone Deacetylase (HDAC) Inhibitor, in relapsed/refractory Hodgkin Lymphoma (HL) patients after high dose chemotherapy and autologous hematopoietic stem cell transplantation will be presented at the 52nd Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida, USA.
› Verified 7 days ago
Karen M Loka, ICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1100 Lake View Dr, Wausau, Wausau, WI 54403 Phone: 715-848-4600 | |
Stacey E Saunders, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 705 S 24th Ave, Wausau, WI 54401 Phone: 715-843-1902 Fax: 715-848-2959 | |
Shannon Cole-cameron, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1100 Lake View Dr, Wausau, WI 54403 Phone: 715-848-4600 Fax: 715-845-5398 | |
Brandon Nite, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2102 N 6th St, Wausau, WI 54403 Phone: 208-403-9508 | |
Julie M Jensen, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1100 Lake View Dr, Wausau, WI 54403 Phone: 715-848-4600 Fax: 715-845-5398 | |
Mr. Travis Jon Forst, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 903 2nd St, Wausau, WI 54403 Phone: 715-842-3346 Fax: 715-842-3344 |